the American Association of Clinical Endocrinologists, urged doctors to “consider treatment for patients who test outside the boundaries of a narrower margin based on a target TSH level of 0.3 to 3.0.” This was in line with what many patients had been saying for years. Once diagnosed, patients with hypothyroidism are treated with supplemental T4 to replace the hormone that their underactive thyroid is no longer producing, and many patients reported that even when their TSH was back in the “normal” range, their symptoms persisted. But the new recommended range sparked great controversy, which
...more